Alan Haycox

4.9k total citations
112 papers, 3.0k citations indexed

About

Alan Haycox is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alan Haycox has authored 112 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Economics and Econometrics, 22 papers in General Health Professions and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alan Haycox's work include Health Systems, Economic Evaluations, Quality of Life (36 papers), Pharmaceutical Economics and Policy (27 papers) and Pharmaceutical studies and practices (9 papers). Alan Haycox is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (36 papers), Pharmaceutical Economics and Policy (27 papers) and Pharmaceutical studies and practices (9 papers). Alan Haycox collaborates with scholars based in United Kingdom, United States and Sweden. Alan Haycox's co-authors include T Walley, Brian Godman, A Bagust, Tom Walley, Björn Wettermark, Dyfrig Hughes, Majid Davari, Lars L. Gustafsson, Angela Boland and Margot Gosney and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Alan Haycox

109 papers receiving 2.9k citations

Peers

Countries citing papers authored by Alan Haycox

Since Specialization

Citations

This map shows the geographic impact of Alan Haycox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Haycox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Haycox more than expected).

Fields of papers citing papers by Alan Haycox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Haycox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Haycox. The network helps show where Alan Haycox may publish in the future.

Co-authorship network of co-authors of Alan Haycox

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Haycox. A scholar is included among the top collaborators of Alan Haycox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Haycox. Alan Haycox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Induction with Foley OR Misoprostol (INFORM) Study dataset. A dataset of 602 women with hypertensive disease in pregnancy, in India, randomised to either Foley catheter or oral misoprostol for induction of labour 2021 ·BMC Research Notes ·Shuchita Mundle, Hillary Bracken, (unknown), (unknown), Brian Faragher, Thomas R. Easterling, Simon Leigh, (unknown), Alan Haycox, M. Turner, (unknown), (unknown), Žarko Alfirević, Beverly Winikoff, Andrew Weeks	0
2	Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions 2019 ·Social Science & Medicine ·(unknown), Paula M. Watson, (unknown), Alan Haycox, Brendan Collins, Lisa Jones, Antony P. Martin, Lee Graves	8
3	Foley Catheterisation Versus Oral Misoprostol for Induction of Labour in Hypertensive Women in India (INFORM): A Multicentre, Open-Label, Randomised Controlled Trial 2018 ·Obstetrical & Gynecological Survey ·Shuchita Mundle, Hillary Bracken, (unknown), (unknown), Brian Faragher, Thomas R. Easterling, Simon Leigh, (unknown), Alan Haycox, M. Turner, Žarko Alfirević, Beverly Winikoff, Andrew Weeks	2
4	Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications 2018 ·PharmacoEconomics - Open ·Arianit Jakupi, Brian Godman, Antony P. Martin, Alan Haycox, (unknown)	7
5	Patent expiry and costs for anti-cancer medicines for clinical use : expiry and costs anti-cancer medicines 2017 ·Generics and Biosimilars Initiative Journal ·Brian Godman, Claudia Wild, Alan Haycox	2
6	Plerixafor is cost‐effective compared to conventional chemotherapy for first‐line haematopoietic stem cell mobilization: Data from the PHANTASTIC trial 2015 ·Journal of Clinical Apheresis ·Antony P. Martin, Sarah Richards, Alan Haycox, Rachel Houten, C McLeod, (unknown), (unknown), (unknown), Richard E. Clark	8
7	The impact of continuous haemofiltration with high-volume fluid exchange during cardiopulmonary bypass surgery on the recovery of patients with impaired renal function: a pilot randomised trial 2013 ·Health Technology Assessment ·Bashir M. Matata, Neeraj Mediratta, Maureen Morgan, (unknown), N. D. A. Scawn, (unknown), Rod Stables, Alan Haycox, Rachel Houten, (unknown), (unknown), (unknown), Aashish Sharma, Keith Wilson	4
8	A pilot randomised controlled trial in intensive care patients comparing 7 days’ treatment with empirical antibiotics with 2 days’ treatment for hospital-acquired infection of unknown origin. 2012 ·Health Technology Assessment ·N. D. A. Scawn, David Saul, Dev S. Pathak, Bashir M. Matata, (unknown), Rod Stables, Samantha Lane, Alan Haycox, Rachel Houten	15
9	Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers 2010 ·BMC Health Services Research ·(unknown), Brian Godman, (unknown), (unknown), Harald Herholz, (unknown), Ott Laius, Saira Jan, Catherine Sermet, Corrine Zara, Marija Kalaba, (unknown), Kristina Garuolienė, Alan Haycox, Silvio Garattini, Lars L. Gustafsson	184
10	Optimizing Decision Making and Resource Allocation in Palliative Care 2009 ·Journal of Pain and Symptom Management ·Alan Haycox	11
11	Health Care Challenges in Iran 2005 ·SHILAP Revista de lepidopterología ·Majid Davari, Alan Haycox, T Walley	6
12	Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age 2003 ·Health Technology Assessment ·(unknown), Margot Gosney, Alan Haycox, Martyn Regan	24
13	Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registry 2003 ·Pharmacoepidemiology and Drug Safety ·Judith Strobl, (unknown), A Bagust, Alan Haycox, Rosalind L Smyth, Deborah Ashby, Tom Walley	7
14	Users’ views on hospital and home care for acute illness in childhood 2001 ·Health & Social Care in the Community ·(unknown), Melanie Maxwell, P. Todd, Alan Haycox, Peter Bundred	45
15	Obesity. About the size of it. 1999 ·PubMed ·Lindsey T. Roberts, Alan Haycox	3
16	The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy 1999 ·Clinical Radiology ·D A Nicholson, Alan Haycox, Clive Kay, Anthony Rate, Stephen E. Attwood, J Bancewicz	37
17	Clinical guidelines---the hidden costs 1999 ·BMJ ·Alan Haycox, A Bagust, Thomas Walley	51
18	Pharmacoeconomics: integrating economic evaluation into clinical trials 1997 ·British Journal of Clinical Pharmacology ·Alan Haycox, Michael Drummond, T Walley	16
19	Evaluating community care : services for people with learning difficulties 1994 ·Open University Press eBooks ·Ken Wright, Alan Haycox, (unknown)	12
20	Haemophilus influenzae type B disease in North-West England 1993 ·Journal of Infection ·(unknown), Edward B. Kaczmarski, (unknown), Alan Haycox	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact